|
2006P-0505:
ANDA for Ursodial Capsules USP, 100 mg 200 mg, and 400 mg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| ACK1
|
| 12/08/2006
|
| 12/08/2006
|
| Federal Government
|
| FDA/DDM to Lachman
Consultant Services, Inc
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Jennie C. Butler
|
|
|
|
|
| CP1
|
| 12/08/2006
|
| 12/08/2006
|
| Private Industry
|
| Lachman Consultant
Services, Inc
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
| Signature:
|
| Robert W. Pollock
| |
|
|
Top
| Up
Page last updated:
January 17, 2007
|
